FDA Clears AI for Heart Failure: Unpacking the AiTiALVSD 510(k)

Podcast: AI in Medicine - curated summaries making complex issues easy to understand · Mike Rawson

Opublikowano: 2026-10-11

We dive into the FDA's recent clearance of AiTiALVSD, an AI tool that predicts left ventricular systolic dysfunction from a standard 12-lead ECG. We break down the clinical validation numbers, the demographic gaps in the training data, and what this specific 510(k) clearance means for cardiology workflows. Key points AiTiALVSD by Medical AI Co., Ltd. received FDA Class II clearance to support the diagnosis of Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%) using 12-lead ECG data.The deep learning model was trained on 400,339 ECGs from 148,624 patients across 16 hospitals in Korea, and evaluated in...